BIO-TECHNE Corp
TECH- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000842023
No open-market purchases or sales by BIO-TECHNE Corp insiders were filed in the last 90 days; 597 institutions reported holding it in 13F filings for Q2 2026, worth $12.3B in total; 3 superinvestors hold it, including Maverick Capital and Weitz Investment Management.
Q1 2025 vs. Q4 2024
How the institutions holding BIO-TECHNE Corp changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 577 | 8 | 578 | +9 |
| Shares | 156.8M | 373.7K | 162.4M | +5.98M (+3.8%) |
| Value | $11.3B | $26.9M | $9.52B | −$1.75B (−15.5%) |
8 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (76)
Institutions that held BIO-TECHNE Corp at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (67)
Institutions that held BIO-TECHNE Corp at the end of Q4 2024 and filed for Q1 2025 without it.
Not filed for Q1 2025 yet (8)
Institutions that held BIO-TECHNE Corp at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 326,892 | $23.5M |
| Zions Bancorporation, N.A. | 38,728 | $2.79M |
| Wetherby Asset Management Inc | 5,102 | $367.5K |
| Kiely Wealth Advisory Group, Inc. | 1,048 | $81.4K |
| Hilltop National Bank | 1,063 | $76.6K |
| Global Retirement Partners, LLC | 857 | $61.7K |
| Legacy Investment Solutions, LLC | 38 | $2.77K |
| Cassady Schiller Wealth Management, LLC | 15 | $1.08K |